The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
Abstract
The considerable therapeutic potential of human multipotent mesenchymal stromal cells (MSC) has generated markedly increasing interest in a wide variety of biomedical disciplines. However, investigators report studies of MSC using different methods of isolation and expansion, and different approaches to characterizing the cells. Thus it is increasingly difficult to compare and contrast study outcomes, which hinders progress in the field. To begin to address this issue, the Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy proposes minimal criteria to define human MSC. First, MSC must be plastic-adherent when maintained in standard culture conditions. Second, MSC must express CD105, CD73 and CD90, and lack expression of CD45, CD34, CD14 or CD11b, CD79alpha or CD19 and HLA-DR surface molecules. Third, MSC must differentiate to osteoblasts, adipocytes and chondroblasts in vitro. While these criteria will probably require modification as new knowledge unfolds, we believe this minimal set of standard criteria will foster a more uniform characterization of MSC and facilitate the exchange of data among investigators.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We tested three different sera lots on previously isolated BM-MSCs and selected the lot (FBS-A) which supported cell growth and maintained the MSC phenotype in accordance with the ISCT minimal criteria [22]—namely trilineage differentiation, expression of CD73, CD90 and CD105, and the absence of CD34, CD45, CD11b, CD19, and HLA-DR markers (Additional file 1: Fig. S1).”
In the citing paper
“Similarly, MSC-based therapies, particularly those utilizing MSCs derived from bone marrow, adipose tissue, or umbilical cord blood, offer substantial regenerative potential due to their ability to differentiate into various tissue types and modulate immune responses [17,18].”
In the citing paper
“For MSCs, the International Society for Cell and Gene Therapy (ISCT) outlines three defining criteria: (1) plastic adherence under standard culture conditions, (2) expression of surface markers CD105, CD73, and CD90, with negative expression of hematopoietic markers (e.g., CD45, CD34, CD14/CD11b, CD79α/CD19, HLA-DR), and (3) trilineage differentiation potential into osteoblasts, adipocytes, and”
From Isolator-based point-of-care manufacturing: a practical solution for GMP-compliant cell and extracellular vesicles therapy production (2025) · cites this paper as Dominici et al., 2006
Citations
Cites
1 retracted
RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrow
Jiang, Y., Jahagirdar, B. N., Reinhardt, R. L., Schwartz, R. E., Keene, C. D., Ortiz-Gonzalez, X. R., Reyes, M., Lenvik, T., Lund, T., Blackstad, M., et al. (2002) · Nature · doi:10.1038/nature00870 · Cited by 5,518
RetractedMultilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., Benhaim, P., Lorenz, H. P., & Hedrick, M. H. (2001) · Tissue Engineering · doi:10.1089/107632701300062859 · Cited by 7,956
Caplan, A. I. (1991) · Journal of Orthopaedic Research · doi:10.1002/jor.1100090504 · Cited by 6,548
Horwitz, E. M., Le Blanc, K., Dominici, M., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Deans, R. J., Krause, D. S., & Keating, A. (2005) · Cytotherapy · doi:10.1080/14653240500319234 · Cited by 2,073
Self-citationRapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow
Colter, D. C., Class, R., DiGirolamo, C. M., & Prockop, D. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070034097 · Cited by 1,019
Self-citationIsolation and characterisation of mesenchymal stem cells from adult mouse bone marrow
Tropel, P., Noël, D., Platet, N., Legrand, P., Benabid, A.-L., & Berger, F. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.12.030 · Cited by 424
Sabatini, F., Petecchia, L., Tavian, M., de Villeroché, V. J., Rossi, G. A., & Brouty-Boyé, D. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700300 · Cited by 298
Baksh, D., Davies, J. E., & Zandstra, P. W. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00106-1 · Cited by 139
Cited by
3D bioprinting of tissues and organs
Murphy, S. V., & Atala, A. (2014) · Nature Biotechnology · doi:10.1038/nbt.2958 · Cited by 7,034
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Mesenchymal stem cell perspective: cell biology to clinical progress
Pittenger, M. F., Discher, D. E., Péault, B. M., Phinney, D. G., Hare, J. M., & Caplan, A. I. (2019) · npj Regenerative Medicine · doi:10.1038/s41536-019-0083-6 · Cited by 2,008
Bourin, P., Bunnell, B. A., Casteilla, L., Dominici, M., Katz, A. J., March, K. L., Redl, H., Rubin, J. P., Yoshimura, K., & Gimble, J. M. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2013.02.006 · Cited by 1,890
Self-citationPhinney, D. G., & Prockop, D. J. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0637 · Cited by 1,908
Self-citation
Metadata
- Authors
- Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M.
- Affiliations
- University of Modena and Reggio Emilia (IT)
- University Children's Hospital Tübingen (DE)
- The University of Texas MD Anderson Cancer Center (US)
- Yale University (US)
- Athersys (United States) (US)
- Princess Margaret Cancer Centre (CA)
- Tulane University (US)
- St. Jude Children's Research Hospital (US)
- Corresponding author
- Dominici, M.
- Venue
- Cytotherapy
- Publisher
- Elsevier BV
- Published
- 2006
- Volume
- 8
- Issue
- 4
- Pages
- 315-317
- ISSN
- 1465-3249 (ISSN-L)
- OpenAlex
- W2025371271
- Cited by
- 17,766
- References
- 8
- Citations by year
- 2026: 640 · 2025: 838 · 2024: 1069 · 2023: 1147 · 2022: 1269 · 2021: 1502 · 2020: 1424 · 2019: 1208 · 2018: 1156 · 2017: 1083 · 2016: 1150 · 2015: 1030 · 2014: 984 · 2013: 948 · 2012: 771
- FWCI
- 82.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Cytotherapy (publishedVersion)
- PubMed (publishedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- multipotent mesenchymal stromal cells, cell surface markers, CD105, CD73, CD90, negative markers, osteogenic differentiation, adipogenesis, chondrogenic differentiation, plastic adherence, cell isolation and expansion
- MeSH terms
- Cell Differentiation, Humans, Antigens, CD, Stromal Cells, Cell Culture Techniques, Multipotent Stem Cells, Mesenchymal Stem Cells, Cell- and Tissue-Based Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. https://app.cochat.ai/papers/10.1080/14653240600855905
- The paper
- Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. https://doi.org/10.1080/14653240600855905
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.